Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide

Cancer Research

Volumn 56, Issue 13, 1996, Pages 2960-2963

  Watanabe, Hideomi ^a   Takehana, Kenji ^b   Date, Masayo ^b   Shinozaki, Tetsuya ^a   Raz, Avraham ^c  

^a GUNMA UNIVERSITY   (Japan)

^b AJINOMOTO CO INC   (Japan)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTIBODY; AUTOCRINE MOTILITY FACTOR; CYTOKINE; FRUCTOSE 6 PHOSPHATE; GLUCOSE 6 PHOSPHATE; GLUCOSE 6 PHOSPHATE ISOMERASE; NEUROLEUKIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER GROWTH; CELL MIGRATION; CELL MOTILITY; CROSS REACTION; ENZYME ACTIVITY; IMMUNOBLOTTING; ISOMERISM; METASTASIS; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RABBIT; TUMOR CELL;

AMINO ACID SEQUENCE; ANIMALS; AUTOCRINE MOTILITY FACTOR; CELL MOVEMENT; FIBROSARCOMA; GLUCOSE-6-PHOSPHATE ISOMERASE; MICE; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NEUROLEUKIN; RABBITS; TUMOR CELLS, CULTURED;

EID: 0030012538     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Singer, S. J., and Kupfer, A. The directed migration of eukaryotic cells. Annu Rev. Cell Biol., 2: 337-365, 1986.
2. Strauh, P., and Weiss, L. Cell locomotion and tumor penetration. Report on a workshop of the EORTC cell surface project group. Eur. J Cancer, 13: 1-12, 1977.
3. Stoker, M., Gherardi, E., Oerryman, M., and Gray, J Scatter factor is a fibroblast-derived modulator of epithelial cell mobility Nature (Lond.), 327: 239-242, 1987
4. Schor, S. L., Schor, A. M , Grey, A. M., and Rushton, G. Foetal and cancer patient fibroblasts produce an autocrine migration stimulating factor not made by normal adult cells. J. Cell Sci., 90: 391-399, 1988.
5. Shimonaka, M., and Yamaguchi, Y. Purification and biological characterization of epitaxin, a fibrobiast derived motility factor for epithelial cells. J. Biol. Chem., 269, 14284-14289, 1944.
6. Koyama, N., Harada, K., Yamamoto, A., Morisaki, N., Saito, Y , and Yoshida, S. Purification and characterization of an autocrine migration factor for vascular smooth muscle cells (SMC), SMC-derived migration factor. J. Biol. Chem., 268: 13301-13308, 1993.
7. Liotta, L. A. Mandler, R., Murano, G., Katz, D. A., Gordon, R. K., Chiang, P. K., and Schiffman, E. Tumor-cell autocrine motility factor. Proc. Natl. Acad. Sci USA, 83: 3302-3306, 1986
8. Silletti, S., and Raz, A Regulation of autocrine motility factor receptor expression in tumor cell locomotion and metastasis. Curr. Top. Microbiol Immunol., in press, 1996.
9. Guirguis, R., Schiffman, E., Liu, B., Birbeck, I., Engel, J., and Liotta, L. A. Detection of autocrine motility factor in urine as a marker of bladder cancer. J. Natl. Cancer Inst., 80 1203-1211, 1988.
10. Watanabe, H., Kanabe, K., and Chirgira, M. Differential purification of autocrine motility factor derived from a murine protein-free fibrosarcoma. Clin. & Exp. Metastasis, 12: 155-163, 1994
11. Hunkpiller, M. W., Lujan, E., Ostrander, F., and Hood, L. E. Isolation of microgram quantities of proteins from polyacrylamide gels for amino acid sequence analysis. Methods Enzymol. 91: 227-236, 1983
12. Hirs, C. H. W. Reduction and S-carboxymethylation of proteins. Methods Enzymol., 11: 199-203, 1967.
13. Mahoney, W. C., and Hermodson, M A Separation of large denatured peptides by reverse phase high performance liquid chromatography. J. Biol. Chem , 255, 11199-11103, 1980.
14. Watanabe, H., Shinozaki, T., Raz, A , and Chigira, M. Expression of autocrine motility factor receptor in serum- and protein-independent fibrosarcoma cells: implications for autonomy in tumor-cell motility and metastasis. Int. J. Cancer, 53, 689-695, 1993.
15. Watanabe, H., Carmi, P., Hogan, V., Raz, T., Silletti, S., Nabi, I. R , and Raz, A Purification of human tumor-cell autocrine motility factor and molecular cloning of its receptor. J. Biol. Chem , 266, 13442-13448, 1991.
16. Gracy, R. W., and Tilley, B. E. Phosphoglucose isomerase of human erythrocytes and cardiac tissue Methods Enzymol., 41: 392-400, 1975
17. Gurney, M. E., Heinrich, S. P., Lee, M. R., and Yin, H Molecular cloning and expression of neuroleukin, a neurotrophic factor for spinal and sensory neurons. Science (Washington DC), 234: 566-574, 1986
18. Faik, P , Walker, J. I. H., Redmill, A. A. M., and Morgan, M. J. Mouse glucose-6-phosphate isomerase and neuroleukin have identical 3′ sequences Nature (Lond.), 332: 455-456, 1988.
19. Chaput, M , Claes, V., Portetelle, D., Cludts, I , Cravador, A., Burney, A , Gras, H., and Tartar, A. The neurotrophic factor neuroleukin is 90% homologous with phosphohexose isomerase. Nature (Lond.), 332, 454-455, 1988.
20. Gurney, M. E., Apatoff, B R , Spear, G. T , Baumel, M. J., Antel, J. P., Bania, M. B., and Reder, A. T. Neuroleukin, a lymphokine product of lectin-stimulated T cells. Science (Washington DC). 234: 574-581, 1986.
21. Gurney, M. E , Apatoff, B. R., and Heinrich, S. P. Suppression of terminal axonal sprouting at the neuromuscular junction by monoclonal antibodies against a muscle-derived antigen of 56,000 daltons. J. Cell Biol. 102: 2264-2272, 1986.
22. Gurney, M. E., Belton, A. C., Cashman, N , and Antel, J. P. Inhibition of terminal axonal sprouting by serum from patients with amyotrophic lateral sclerosis. N Engl. J Med , 311, 933-939, 1984.
23. Lee, M. R., Ho, D. D., and Gurney, M. E. Functional interaction and partial homology between human immunodeficiency virus and neuroleukin. Science (Washington DC), 237: 1047-1051, 1987
24. Ho, D. D , Pomerantz, R. J., and Kaplan, J. C. Pathogenesis of infection with human immunodeficiency virus. N. Engl J. Med. 317: 278-286, 1987.
25. Gurney, M. E. Suppression of sprouting at the neuromuscular junction by immune sera. Nature (Lond.), 307: 546-548, 1984.
26. Guirguis, R., Margulies, I., Taraboletti, G., Schiffman, E., and Liotta, L. Cytokine-induced pseudopodial protrusion is coupled to tumor cell migration. Nature (Lond ), 329: 261-263, 1987.
27. Baumann, M., and Brand, K. Purification and characterization of phosphohexose isomerase from human gastrointestinal carcinoma and its potential relationship to neuroleukin. Cancer Res, 48, 7018-7021, 1988.
28. Baumann, M., Kappl, A., Lang, T., Brand, K., Siegfried, W , and Paterok, E. The diagnostic validity of the serum tumor marker phosphohexose isomerase (PHI) in patients with gastrointestinal, kidney, and breast cancer. Cancer Invest., 8, 351-356, 1990
29. Filella, X., Molina, R., Jo, J., Mas, E , and Ballesta, A M. Serum phosphohexose isomerase activities in patients with colorectal cancer. Tumor Biol., 12: 360-367, 1991
30. Patel, P S., Raval, G. N., Rawal, R. M., Patel, G H., Balar, D. B., Shah, P M., and Patel, D D Comparison between serum levels of carcinoembryonic antigen, sialic acid and phosphohexose isomerase in lung cancer. Neoplasia, 42: 271-274, 1995.
31. Bodansky, O. Serum phosphohexose isomerase in cancer. II. As an index of tumor growth in metastatic carcinoma of the breast. Cancer (Phila.), 7: 1200-1226, 1954.
32. Schwartz, M. K. Laboratory aids to diagnosis-enzymes. Cancer (Phila.), 37: 542-548, 1976.
33. Voigt, W , Rothauge, C. F , and Schaffer, K. The value of urine phosphohexose isomerase activity in comparison with urine cytology. First diagnosis and tumor after-care in patients with cancer of the urinary bladder Urol. AUSG A, 33: 235-242, 1994.
34. Yoshimura, A., Kuwazuru, Y., Furukawa, T , Yoshida, H., Yamada, K , and Akiyama, S. Purification and tissue distribution of human thymidine phosphorylase, high expression in lymphocytes, reuculocytes and tumors. Biochim. Biophys. Acta, 1034: 107-113, 1990.
35. Murata, J., Lee, H Y., Clair, T., Krutzsch, H C., Arestad, A. A., Sobel, M. E , Liotta, L. A , and Stracke, M. L. cDNA cloning of human tumor motility-stimulating protein, autotaxin, reveals a homology with phosphodiesterases J Biol Chem., 269: 30479-30484, 1994.